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Abstract
Introduction. Some biliary strictures may be manageable by percutaneous interventional radiologic techniques (PIRT), but
long-term efficacy of this approach is scarce. Methods. We reviewed retrospectively all patients with biliary strictures
secondary to traumatic bile duct injury or strictured bilioenteric anastomoses. Patients in whom the initial management was
by PIRT from 1998 through 2003 were selected. Subjects with sclerosing cholangitis, hepatic transplantation, or malignant
strictures were excluded. Data were obtained from medical records and/or direct patient contact. Comparisons were made
by Fisher’s exact test and Wilcoxon rank-sum test. Results. Twenty-seven patients with biliary strictures were treated by
PIRT. Mean age was 54 years (range 1186). Most frequent etiology was laparoscopic cholecystectomy injury in 11 patients
(41%). Eight patients (29%) had undergone biliary resection for malignancy, seven (26%) a pancreatoduodenectomy, and
one for presumed ischemic cholangiopathy; no strictures were secondary to neoplastic recurrence. PIRT was successful in
10 of 11 patients (91%) with short, isolated bile duct strictures secondary to laparoscopic cholecystectomy and in seven of
15 patients (41%) with strictured bilioenteric anastomosis, but not in the patient with ischemic cholangiopathy. Twenty
patients (74%) were stent-free at follow-up. Anastomotic biliary strictures were more likely to fail PIRT than isolated
strictures secondary to laparoscopic cholecystectomy injury (p0.02). Conclusion. Percutaneous balloon dilatation and
stenting can be an effective strategy for patients with bile duct strictures, especially short bile duct strictures after
laparoscopic cholecystectomy. Anastomotic strictures are associated with less good results when managed by PIRT but are
successful in up to 40% of patients.
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Introduction
Percutaneous interventional radiologic techniques
(PIRT) have had an increasingly important role in
the multidisciplinary diagnosis and management of
biliary strictures. Before interventional techniques
(radiologic, endoscopic) were developed, operative
intervention was the only option for definitive treat-
ment of biliary strictures. While excellent results have
been reported with a primary operative approach,
some benign biliary strictures may be amenable to a
non-operative, interventional approach, thereby
avoiding the morbidity and mortality of an operative
approach. In recent years, percutaneous transhepatic
biliary interventional techniques have been used
increasingly to evaluate and treat selected patients
with complex biliary lesions; however, little data in the
literature address the long-term efficacy of this
approach. Indeed, there is no consensus regarding
which patients are best treated by this form of
interventional treatment.
Methods
We reviewed retrospectively all patients with biliary
strictures secondary to traumatic operative bile duct
injury or who had an operative bilioenteric anasto-
mosis performed that strictured subsequently. We
then selected all those patients managed by PIRT at
Mayo Clinic Rochester between 1 January 1998 and
31 December 2003.
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Patients with a history of primary sclerosing cho-
langitis, hepatic transplantation, or malignant stric-
tures were excluded. Demographic, clinical,
histopathologic, treatment, survival, and outcome
variables were collected and analyzed. Clinical notes,
imaging studies, operative reports, and pathology
reports were reviewed to determine the etiology and
type of stricture whenever possible. Clinical symp-
toms, pre and post-intervention cholangiograms, re-
sults of liver function tests, and need for continued
intervention were used to assess outcome. Data were
obtained from the hospital record or by direct patient
contact via a mailed, written questionnaire. The
results were defined arbitrarily as ‘‘excellent’’ when
the patient was asymptomatic, had normal liver
function tests, and required no further treatment;
‘‘good’’ if mild symptoms were present and liver
function tests were mildly abnormal (serum activities
of g-glutamyl-transferase, aminotransferases, or alka-
line phosphatase equal to or less than 1.5 times the
upper limit of the reference range) but no further
intervention was needed; ‘‘fair’’ when the stricture was
ultimately managed non-operatively, but the patient
still had ongoing symptoms (e.g. intermittent cholan-
gitis) or abnormal liver function tests (serum activities
of g-glutamyl-transferase, aminotransferases, or alka-
line phosphatase greater than 1.5 times the upper limit
of the reference range); or ‘‘poor’’ if a stricture
recurred, was symptomatic, required active interven-
tional treatment, or was managed ultimately by
operative intervention.
We decided specifically not to describe the level of
the strictures according to available classification
systems (i.e. Bismuth, Strasberg) due to the hetero-
geneity of the lesions and the different mechanisms by
which the strictures occurred (primary/iatrogenic vs.
anastomotic).
This study was approved by the Mayo Clinic
Institutional Review Board and complied with the
HIPPA and Minnesota State regulations.
Clinical management
All patients underwent percutaneous transhepatic
cholangiography (PTC) followed by placement of
percutaneous biliary drainage catheters (PBD). This
procedure was performed in a standard fashion and is
described briefly below. All patients were treated with
intravenous antibiotics before the procedure. Intrave-
nous conscious sedation was administered by anesthe-
siology personnel consisting either of diprivan or a
combination of midazolam and sublimazime. Using
the right midline, transaxillary approach, a 22-gauge
Chiba needle (Cook, Inc., Bloomington, IN) was
inserted, and iodinated contrast material was injected
to opacify the intrahepatic bile ducts and to define the
level and nature of the bile duct lesion. Based on the
percutaneous cholangiogram, an appropriate intrahe-
patic duct was selected and punctured, often a right,
laterally oriented duct. When the injury was at or near
the bifurcation, both right and left hepatic ducts were
accessed. Attempts were made to cross the injury at
the time of initial tube insertion. At our institution, the
initial catheter and guide wire combination used most
frequently was a five-Fr glide head catheter (Boston
Scientific, Boston, MA) and an angled 0.035?? hydro-
philic Glidewire (Boston Scientific). This combination
was manipulated intraductally through a small percu-
taneous sheath. Other catheter and guide-wire combi-
nations were used when this initial approach failed.
After crossing the biliary lesion, the stricture was
dilated with an appropriately sized (usually 68 mm
diameter), high-pressure balloon. Finally, a locking-
loop biliary drainage catheter (either 8.5 or 10 Fr size)
(Cook Inc.) was inserted with its tip coiled beyond the
site of obstruction. After the procedure, the catheter
was placed initially to gravity drainage. The patient
was discharged to home when clinically stable often
with the catheter capped and internalized.
At two- to three-month intervals, patients returned
to our institution on an outpatient basis for routine
biliary catheter exchanges, balloon dilatation of the
underlying stricture, and re-evaluation of hepatic
function and overall clinical status. The overall dura-
tion of biliary intubation was determined by the
location of the injury, the patient’s clinical course,
and follow-up cholangiograms. Prior to removal of the
stenting catheters, most patients underwent a clinical
trial with the tube capped for two weeks prior to
removal.
For the purposes of analysis, the results were
grouped into two categories: Group A: patients with
a good response to PIRT (excellent and good out-
comes) and Group B: patients who failed PIRT (fair
and poor outcomes). Data were analyzed by descrip-
tive statistics, and comparisons between groups were
performed using Fisher’s exact test and Wilcoxon
rank-sum test with SPSS 13.0 statistical package
(Chicago, IL). Differences were considered clinically
important at p50.05. Data are presented as x9SD
unless specified otherwise.
Results
Patients
A total of 27 patients with biliary strictures met our
criteria for inclusion during the time period. There
were 15 men (56%) and 12 women (44%) with an age
of 54919 years (range 1186). The most frequent
etiology of biliary stricture (Table I) was ductal injury
during laparoscopic cholecystectomy in 11 patients
(41%).
Eight patients (30%) had undergone biliary resec-
tion for cholangiocarcinoma, and seven patients
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(26%) had a biliary anastomosis during pancreato-
duodenectomy as the cause of the stricture, but none
of postoperative biliary strictures were secondary to
neoplastic recurrence at the stricture site. Three of
these patients had undergone radiation therapy prior
to developing the stricture.
Treatment
The majority (24 patients) were managed by
a combination of balloon dilatation and stenting
(Table II). Mean number of balloon dilatations was
2.7 (range 17) with just over half of the patients
requiring one or two dilatations (Table II). One patient
developed transient pancreatitis after initial percuta-
neous transhepatic cholangiography; there were no
treatment-related deaths.
Follow-up
Adequate follow-up was available for 26 of the 27
patients. The mean duration of follow-up was 42925
months (range 281). Group A patients (treatment
success group) were followed a mean of 46 months
(range 581). The only patient lost to follow-up had a
capped external drainage catheter, and although the
patient was asymptomatic and had normal liver
function parameters at last follow-up, we considered
him a treatment failure. Eight patients died during
follow-up from several different causes not related to
the biliary stricture management, including three in
Group A and five in Group B.
Outcomes
Overall, treatment was considered a success in 63% of
patients. Interventional radiologic management was
successful in 10 of 11 patients (91%) with a bile duct
stricture related to a laparoscopic cholecystectomy and
in seven of 15 patients (41%) with anastomotic
strictures.
When comparing Group A to Group B, we found
no difference in the mean number of balloon dilata-
tions (2.7 vs. 2.7; pNS) or in the duration of
endobiliary stenting (eight vs. 10 months; pNS),
respectively. We did find an association between a
diagnosis of cancer and outcome; patients with cancer
were more likely to have a treatment failure than
patients without a history of cancer (p0.02). The
duration of endobiliary stenting was less than four
months in 13 patients (48%), four to nine months in
four (15%), and greater than nine months in nine
(33%). The duration of time of endobiliary stenting
did not correlate with outcomes.
Of the 10 treatment failures (37%), one patient
underwent successful operative reconstruction, and
one was lost to follow-up. The remaining eight
patients were not considered good candidates for
operative management. Three were managed by
active, radiologic intervention, three had stents placed
(one endoscopic, two percutaneous), and one each
was managed by continuous externalinternal biliary
drainage or intermittent courses of antibiotics for
recurrent cholangitis. Twenty patients (74%) were
stent-free at last follow-up, including the 16 in Group
A and four in Group B. Variables potentially related to
treatment outcomes are shown in Table III.
Table I. Etiology of biliary strictures.
Etiology n %
Laparoscopic bile duct injury 11 40
Pancreatoduodenectomy 7 26
Resection of extrahepatic biliary tree 5 19
Hepatectomy with resection of extrahepatic biliary tree 3 11
Presumed ischemic cholangiopathy 1 4
Table II. Interventional radiology management.
Interventions n
Balloon dilatation and stenting 24
Balloon dilatation only 2
Balloon dilatationexpandable metallic stent 1
Number of dilatations
1 8
2 7
3 6
5 3
6 2
7 1
Mean 2.7
Table III. Interventional radiology management.
Etiology
Success/
Total % p
Laparoscopic bile duct injury* 10/11 91
Pancreatoduodenectomy 2/7 29
Resection of extrahepatic biliary tree 3/5 60
Hepatectomy 2/2
Ischemic cholangiopathy 0/1
Intervention
Balloon dilatation and stenting 15/24 63
Balloon dilatation only 1/2
Balloon dilatationexpandable metallic
stent
1/1
Duration of stenting$
B4 months 10/13 77 0.63
Four to nine months 3/4 75
9 months 4/9 44
Cancer diagnosis
Yes 2/8 25 0.02
No 15/19 79
*Strictures were selected that were isolated and short in length
B2 cm.
$One patient was lost to follow-up with a catheter stenting the
stricture site and the duration of stenting is not known.
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Discussion
The number of benign biliary strictures has increased
in the recent years, in part as a result of the wide-
spread use of laparoscopic cholecystectomy and the
increase in the volume of hepatobiliary surgery.
Iatrogenic bile duct injuries after upper gastrointest-
inal tract surgery (especially cholecystectomy) are the
most common cause of postoperative biliary strictures
and account for over 80% of the patients in some
series [1]. Management of biliary strictures continues
to be a challenging problem and requires a multi-
disciplinary approach.
Repair of bile duct injuries secondary to cholecys-
tectomy increases the cost of an uncomplicated
procedure markedly and carries substantial morbidity
and mortality. It has been estimated that a bile duct
injury adds over $50,000 to the cost of care [2]. These
figures only take into account the cost of medical care
and fail to include the loss in productivity and other
additional expenses.
Operative approaches for repair of biliary injuries
are a time-tested management option and achieve
good long-term results with minimal morbidity and
mortality in most patients [36]. Our study of patients
who underwent operative reconstruction of laparo-
scopic cholecystectomy-induced bile duct injuries at
Mayo Clinic, Rochester found that the quality of life
assessed a minimum of five years after reconstruction
was as good as that of a control population after
uneventful laparoscopic cholecystectomy [7].
Endoscopic management with dilatation, followed
by insertion of plastic, biliary stents has also been used
with good outcomes in other series [811]. As with
PIRT, this technique requires biliary-enteric continu-
ity to be present, but it also requires the stricture zone
to be accessible endoscopically accessible via the
gastrointestinal tract, a difficult procedure in those
patients with Roux-en-Y anastomoses or more com-
plex postoperative anatomy. Selected biliary strictures
may be managed by PIRT to avoid the morbidity of an
operation and allow the patient to return to an active
life sooner. Other series have reported the results of
PIRT for laparoscopy-associated bile duct injuries,
but data on the long-term efficacy is scarce [1215].
Post-transplant biliary strictures also have been man-
aged successfully by PIRT [16,17].
Patients selected for analysis in our study were
those with biliary strictures secondary to operative
traumatic bile duct injury or who had an operative
bilioenteric anastomosis performed that strictured
subsequently and that either were not amenable to
endoscopic access or were not good candidates for
operative or endoscopic management. Patients with a
history of primary sclerosing cholangitis, hepatic
transplantation, or malignant strictures were not
included in this analysis, because they represent
different diseases mechanisms. In this series, 27
patients with biliary strictures treated with PIRT
were followed for a mean 42 of months and had an
overall successful outcome in 63% of the patients with
no treatment-related mortality. In the subgroup of
patients that had a laparoscopic cholecystectomy as
the cause of the stricture and were deemed candidates
for PIRT based on the type and location of the bile
duct stricture, PIRT was successful in 91% of the
patients (10 of 11 patients). In those 12 patients with
strictured bilioenteric anastomoses, the long-term
success rate was less (5; 41%). The reasons for the
difference in outcomes may be explained by the
different mechanisms by which the bile duct strictures
occur. Two series from the Johns Hopkins Hospital
have reported success rates of 55 and 59%, respec-
tively for percutaneous management of biliary stric-
tures most of which were secondary to bile duct injury
during cholecystectomy [12,13]. These results are
comparable to the overall success rate of our series but
are inferior to our results for primary strictures
(secondary to laparoscopic cholecystectomy). These
difference may be explained by several factors, such as
different selection criteria of patients and different
durations of follow-up between the studies, because
greater durations of follow-up may find more stricture
recurrences.
We found an association between a history of cancer
and outcomes; patients with strictures in association
with operative procedures for cancer were more likely
to fail PIRT than patients without a history of cancer
(p0.02). These results suggest that malignancy may
have had a role in the genesis of the anastomotic
stricture. Nevertheless, in none of the patients in our
series was recurrent neoplasm ever demonstrated as
the cause of the stricture. An alternative explanation
for this difference may be the use of adjuvant
abdominal radiation therapy in some of those pa-
tients.
Duration of endobiliary stenting did not correlate
with outcomes. This finding contrasts with results
reported from other series in which PIRT treatment
was more likely to fail in patients stented for shorter
durations of time [13].
One patient in our series was managed successfully
with balloon dilatation and the implantation of a self-
expandable metallic stent. Controversy exists regard-
ing the use of ‘‘uncovered’’ metallic stents in patients
with benign biliary conditions, because these stents
are difficult, if not impossible to remove. Rossi et al.
[18] first reported the use of uncovered metal stents in
patients with postoperative biliary strictures after
failed attempts at operative repair and endoscopic
balloon dilatation; of the 17 patients managed in this
fashion, 14 had relief from jaundice and cholangitis at
a mean follow-up of eight months.
A recent series addressing removal of metallic stents
placed to relieve biliary strictures found that removal
of uncovered stents was difficult, while removal of
covered stents with a snare was a relatively simple and
safe procedure and therefore recommended that a
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covered stent be considered as initial therapy when
malignant biliary obstruction was suspected but un-
confirmed [19]. Development of self-expandable,
covered stents specifically designed to be removed at
a later date may change current management strate-
gies by promoting their use in benign strictures.
In summary, our data show that PIRT can be used
with good or excellent outcomes in selected patients
as a primary intervention or as an adjunct to operative
management. PIRT is less invasive than operative
intervention and may be safer in poor operative
candidates and in those patients whose anatomy
makes endoscopic instrumentation technically diffi-
cult; indeed, PIRT may represent their only non-
operative management option.
We acknowledge the limitations of this retrospective
chart review in which the patient groups reported are
heterogeneous and small, potentially leading to a type
II error in some cases. The results of this study are also
affected by the active management decisions made by
the involved clinical physicians during the years of this
review, whereby young healthy patients with bile duct
injuries ideal for operative repair were often not
considered for a trial of PIRT, but instead underwent
immediate operative reconstruction. These considera-
tions, together with the fact that several strictures were
reported more than 10 years after a biliary injury,
bilioenteric anastomosis or attempt at operative repair
underscores the need for prospective studies with
long-term follow-up before considering any procedure
a good option for management.
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